ELIZABETH STANFORD: Open Payments
NPI 1225459118 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 29 payments from 6 companies in 2025. Trend: 2023 $848 · 2024 $495 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 23 | $267 |
| Janssen Biotech, Inc. | 2 | $57 |
| GENZYME CORPORATION | 1 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| PFIZER INC. | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $27 |
Products named: JEMPERLI, OJJAARA, BLENREP, WAYRILZ, KISQALI, TECVAYLI, TIVDAK, INJECTAFER.
Industry payments across VA — which companies pay providers there.
